Xenografted human amniotic fluid-derived stem cell as a cell source in therapeutic angiogenesis

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 66-75

  Liu, Yen Wen ^a,b   Roan, Jun Neng ^a   Wang, Saprina P H ^b   Hwang, Shiaw Min ^c   Tsai, Ming Song ^d   Chen, Jyh Hong ^a   Hsieh, Patrick C H ^a,b,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Amniotic fluid derived stem cell; Angiogenesis; Cell therapy; Ischemia; Matrix metalloproteinase

Indexed keywords

CELL MARKER; GELATINASE B; STROMELYSIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

AMNION FLUID; AMNIOTIC FLUID DERIVED STEM CELL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CAPILLARY; CELL DIFFERENTIATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FEMALE; HINDLIMB; HUMAN; HUMAN CELL; ILIAC ARTERY; IN VITRO STUDY; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STEM CELL TRANSPLANTATION; UMBILICAL VEIN ENDOTHELIAL CELL;

AMNIOTIC FLUID-DERIVED STEM CELL; ANGIOGENESIS; CELL THERAPY; ISCHEMIA; MATRIX METALLOPROTEINASE;

AMNIOTIC FLUID; ANIMALS; CELL LINEAGE; CELLS, CULTURED; EMBRYONIC STEM CELLS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 84883778795     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.072     Document Type: Article

References (34)

1. K. Ouriel Peripheral arterial disease Lancet 358 2001 1257 1264
2. S. Fazel, M. Cimini, and L. Chen Cardioprotective c-kit + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines J Clin Invest 116 2006 1865-1177
3. S. Dimmeler, and A.M. Zeiher Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 82 2004 671 677
4. S.W. Cho, S.H. Moon, and S.H. Lee Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia Circulation 116 2007 2409 2419
5. S.W. Kim, H. Han, and G.T. Chae Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model Stem Cells 24 2006 1620 1626
6. T. Reffelmann, S. Könemann, and R.A. Kloner Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy J Am Coll Cardiol 53 2009 305 308
7. A.J. Boyle, S.P. Schulman, J.M. Hare, and P. Oettgen Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the next step Circulation 114 2006 339 352
8. N. Ma, C. Stamm, and A. Kaminski Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice Cardiovasc Res 66 2005 45 54
9. P. Oettgen, A.J. Boyle, S.P. Schulman, and J.M. Hare Cardiac stem cell therapy. Need for optimization of efficacy and safety monitoring Circulation 114 2006 353 358
10. C. Holden Stem cells - versatile stem cells without the ethical baggage? Science 315 2007 170
11. P. De Coppi, G. Bartsch Jr., and M.M. Siddiqui Isolation of amniotic stem cell lines with potential for therapy Nat Biotechnol 25 2007 100 106
12. M.S. Tsai, J.L. Lee, Y.J. Chang, and S.M. Hwang Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol Hum Reprod 19 2004 1450 1456
13. T. Hampton Stem cells obtained from amniotic fluid JAMA 297 2007 795
14. Y.J. Kim, H.K. Kim, H.H. Cho, Y.C. Bae, K.T. Suh, and J.S. Jung Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularisation in response to vascular ischemia Cell Physiol Biochem 20 2007 867 876
15. K. Bayne Revised guide for the care and use of laboratory animals available. American Physiological Society Physiologist 39 199 1996 208 211
16. Z.C.W. Tang, W.Y. Liao, A.C.L. Tang, S.J. Tsai, and P.C.H. Hsieh The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan Biomaterials 32 2011 75 86
17. M.F. Burbridge, F. Cogé, J.P. Galizzi, J.A. Boutin, D.C. West, and G.C. Tucker The role of the matrix metalloproteinases during in vitro vessel formation Angiogenesis 5 2002 215 226
18. X. Jin, M. Yagi, and N. Akiyama Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis Cancer Sci 97 2006 1327 1334
19. W. Huang, T. Wang, and D. Zhang Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9 Stem Cells Dev 21 2012 778 789
20. T.G. Ebrahimian, C. Squiban, and T. Roque Plasminogen activator inhibitor-1 controls bone marrow-derived cells therapeutic effect through MMP9 signalling: role in physiological and pathological wound healing Stem Cells 30 2012 1436 1446
21. M.A. Laflamme, and C.E. Murry Regenerating the heart Nat Biotechnol 23 2005 845 856
22. V.F. Segers, and R.T. Lee Stem-cell therapy for cardiac disease Nature 451 2008 937 942
23. Y.C. Yeh, W.Y. Lee, and C.L. Yu Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model Biomaterials 31 2010 6444 6453
24. S.W. Kim, H.Z. Zhang, C.E. Kim, H.S. An, J.M. Kim, and M.H. Kim Amniotic mesenchymal stem cells have robust angiogenic properties and are effective in treating hindlimb ischaemia Cardiovasc Res 93 2012 525 534
25. J. Kim, Y. Lee, and H. Kim Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells Cell Prolif 40 2007 75 90
26. A. Chiavegato, S. Bollini, and M. Pozzobon Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat J Mol Cell Cardiol 42 2007 746 759
27. P.C. Hsieh, M.E. Davis, J. Gannon, C. MacGillivray, and R.T. Lee Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers J Clin Invest 116 2006 237 248
28. P.C. Hsieh, C. MacGillivray, J. Gannon, F.U. Cruz, and R.T. Lee Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity Circulation 114 2006 637 644
29. N.K. Cho, L. Keyes, and E. Johnson Developmental control of blood cell migration by the Drosophila VEGF pathway Cell 108 2002 865 876
30. K. Hattori, B. Heissig, and Y. Wu Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1 (+) stem cells from bone-marrow microenvironment Nat Med 8 2003 841 849
31. B. Heissig, K. Hattori, and S. Dias Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand Cell 109 2002 625 637
32. M. Hollborn, C. Stathopoulos, A. Steffen, P. Wiedemann, L. Kohen, and A. Bringmann Positive feedback regulation between MMP-9 and VEGF in human RPE cells Invest Ophthalmol Vis Sci 48 2007 4360 4367
33. N. Siegel, M. Rosner, M. Hanneder, A. Freilinger, and M. Hengstschläger Human amniotic fluid stem cells: a new perspective Amino Acids 35 2008 291 293
34. S. Cipriani, D. Bonini, and E. Marchina Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain Cell Biol Int 31 2007 845 850